Literature DB >> 21886739

Stevens-Johnson syndrome associated with cytomegalovirus infection in a child with ependymoma.

Maria João Cruz1, Alberto Mota, Teresa Baudrier, Maria João Gil-da-Costa, Filomena Azevedo.   

Abstract

BACKGROUND: Stevens-Johnson syndrome is an uncommon, acute life-threatening disease characterized by extensive epidermal sloughing and mucositis. In childhood, as in adulthood, this condition is mostly related to drugs, in particular antibiotics. Only a few cases reported were firmly attributed to infectious agents, mainly Mycoplasma pneumonia but the causative role of infectious microorganisms seems particularly relevant in pediatric patients. The seriousness of this condition imposes a prompt recognition and the early withdrawal of the potential causative drugs or the institution of directed measures against infectious agents (depending on the suspected etiology), as well as a supportive and more specific therapy. Some treatments claim to halt the progression of skin detachment, but remain of unproven benefit due to the lack of prospective, well controlled, randomized clinical trials. MAIN OBSERVATIONS: We report a case of a 2-year-old boy admitted in our hospital for the treatment of an ependymoma of the posterior fossa, who developed a Stevens-Johnson syndrome associated most probably with a cytomegalovirus infection. He was successfully treated with high dose intravenous immunoglobulin and gancyclovir.
CONCLUSION: To the best of our knowledge, this is the first case of SJS associated with CMV infection.

Entities:  

Keywords:  Stevens-Johnson syndrome; child; cytomegalovirus; ganciclovir; intravenous immunoglobulin; perianal

Year:  2010        PMID: 21886739      PMCID: PMC3157806          DOI: 10.3315/jdcr.2010.1043

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  9 in total

1.  Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system.

Authors:  R Ball; L K Ball; R P Wise; M M Braun; J A Beeler; M E Salive
Journal:  Pediatr Infect Dis J       Date:  2001-02       Impact factor: 2.129

2.  Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.

Authors:  Maurizio Stella; Alessandra Clemente; Daniele Bollero; Daniela Risso; Paola Dalmasso
Journal:  Burns       Date:  2007-05-01       Impact factor: 2.744

3.  Mycoplasma pneumoniae-induced pneumonia with Stevens-Johnson syndrome of acute atypical course.

Authors:  Magdalena Walicka; Magdalena Majsterek; Adriana Rakowska; Monika Słowińska; Justyna Sicińska; Beata Góralska; Marta Ptasińska; Lidia Rudnicka; Ewa Marcinowska-Suchowierska
Journal:  Pol Arch Med Wewn       Date:  2008 Jul-Aug

Review 4.  Primary varicella infection associated with stevens-johnson syndrome in a Turkish child.

Authors:  Ali Bay; Necmettin Akdeniz; Omer Calka; Mustafa Kösem; Ahmet Faik Oner; Murat Doğan
Journal:  J Dermatol       Date:  2005-09       Impact factor: 4.005

Review 5.  Cytomegalovirus infection in normal and immunocompromised humans. A review.

Authors:  F Drago; M G Aragone; C Lugani; A Rebora
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

6.  Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.

Authors:  Y-L Choi; J-A Kim; K-T Jang; D-S Kim; W-S Kim; J-H Lee; J-M Yang; E-S Lee; D-Y Lee
Journal:  Br J Dermatol       Date:  2006-11       Impact factor: 9.302

Review 7.  Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding.

Authors:  Lars E French
Journal:  Allergol Int       Date:  2006-03       Impact factor: 5.836

Review 8.  Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature.

Authors:  Denise W Metry; Peter Jung; Moise L Levy
Journal:  Pediatrics       Date:  2003-12       Impact factor: 7.124

9.  Mycoplasma pneumoniae associated with Stevens Johnson syndrome.

Authors:  J M Mulvey; A Padowitz; M Lindley-Jones; R Nickels
Journal:  Anaesth Intensive Care       Date:  2007-06       Impact factor: 1.669

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.